Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Significance of CSF NfL and tau in ALS.

Schreiber S, Spotorno N, Schreiber F, Acosta-Cabronero J, Kaufmann J, Machts J, Debska-Vielhaber G, Garz C, Bittner D, Hensiek N, Dengler R, Petri S, Nestor PJ, Vielhaber S.

J Neurol. 2018 Nov;265(11):2633-2645. doi: 10.1007/s00415-018-9043-0. Epub 2018 Sep 5.

PMID:
30187162
2.

Dyspnea in Amyotrophic Lateral Sclerosis: Rasch-Based Development and Validation of a Patient-Reported Outcome (DALS-15).

Vogt S, Petri S, Dengler R, Heinze HJ, Vielhaber S.

J Pain Symptom Manage. 2018 Nov;56(5):736-745.e2. doi: 10.1016/j.jpainsymman.2018.08.009. Epub 2018 Aug 24.

PMID:
30145215
3.

Global Hippocampal Volume Reductions and Local CA1 Shape Deformations in Amyotrophic Lateral Sclerosis.

Machts J, Vielhaber S, Kollewe K, Petri S, Kaufmann J, Schoenfeld MA.

Front Neurol. 2018 Jul 20;9:565. doi: 10.3389/fneur.2018.00565. eCollection 2018.

4.

Quantitative Susceptibility MRI to Detect Brain Iron in Amyotrophic Lateral Sclerosis.

Acosta-Cabronero J, Machts J, Schreiber S, Abdulla S, Kollewe K, Petri S, Spotorno N, Kaufmann J, Heinze HJ, Dengler R, Vielhaber S, Nestor PJ.

Radiology. 2018 Oct;289(1):195-203. doi: 10.1148/radiol.2018180112. Epub 2018 Jul 24.

PMID:
30040038
5.

Reader response: Serum neurofilament light is sensitive to active cerebral small vessel disease.

Schreiber S, Scheumann V, Perosa V, Vielhaber S, Assmann A.

Neurology. 2018 Jun 12;90(24):1126. doi: 10.1212/WNL.0000000000005672. No abstract available.

PMID:
29891580
6.

Prefrontal cortical thickness in motor neuron disease.

Machts J, Cardenas-Blanco A, Acosta-Cabronero J, Kaufmann J, Loewe K, Kasper E, Schuster C, Prudlo J, Vielhaber S, Nestor PJ.

Neuroimage Clin. 2018 Mar 2;18:648-655. doi: 10.1016/j.nicl.2018.03.002. eCollection 2018.

7.

[Rhinocerebral Mucormycosis].

Mertens A, Barche D, Scheinpflug L, Scholz FG, Vielhaber S, Scherlach C, Tröger U, Geginat G, Färber J, Arens C.

Laryngorhinootologie. 2018 Aug;97(8):550-554. doi: 10.1055/a-0619-5143. Epub 2018 May 16. German.

PMID:
29768642
8.

Differential involvement of forearm muscles in ALS does not relate to sonographic structural nerve alterations.

Schreiber S, Schreiber F, Debska-Vielhaber G, Garz C, Hensiek N, Machts J, Abdulla S, Dengler R, Petri S, Nestor PJ, Vielhaber S.

Clin Neurophysiol. 2018 Jul;129(7):1438-1443. doi: 10.1016/j.clinph.2018.04.610. Epub 2018 May 1.

PMID:
29751209
9.

Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia.

Giordano I, Harmuth F, Jacobi H, Paap B, Vielhaber S, Machts J, Schöls L, Synofzik M, Sturm M, Tallaksen C, Wedding IM, Boesch S, Eigentler A, van de Warrenburg B, van Gaalen J, Kamm C, Dudesek A, Kang JS, Timmann D, Silvestri G, Masciullo M, Klopstock T, Neuhofer C, Ganos C, Filla A, Bauer P, Tezenas du Montcel S, Klockgether T.

Neurology. 2017 Sep 5;89(10):1043-1049. doi: 10.1212/WNL.0000000000004311. Epub 2017 Aug 9.

PMID:
28794257
10.

Peripheral nerve atrophy together with higher cerebrospinal fluid progranulin indicate axonal damage in amyotrophic lateral sclerosis.

Schreiber S, Debska-Vielhaber G, Abdulla S, Machts J, Schreiber F, Kropf S, KÖrtvelyessy P, KÖrner S, Kollewe K, Petri S, Dengler R, Kunz WS, Nestor PJ, Vielhaber S.

Muscle Nerve. 2018 Feb;57(2):273-278. doi: 10.1002/mus.25682. Epub 2017 May 22.

PMID:
28472860
11.

Widespread temporo-occipital lobe dysfunction in amyotrophic lateral sclerosis.

Loewe K, Machts J, Kaufmann J, Petri S, Heinze HJ, Borgelt C, Harris JA, Vielhaber S, Schoenfeld MA.

Sci Rep. 2017 Jan 9;7:40252. doi: 10.1038/srep40252.

12.

Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study.

Kopitzki K, Oldag A, Sweeney-Reed CM, Machts J, Veit M, Kaufmann J, Hinrichs H, Heinze HJ, Kollewe K, Petri S, Mohammadi B, Dengler R, Kupsch AR, Vielhaber S.

Neuroimage Clin. 2016 Sep 29;12:666-672. eCollection 2016.

13.

Biallelic Mutations of VAC14 in Pediatric-Onset Neurological Disease.

Lenk GM, Szymanska K, Debska-Vielhaber G, Rydzanicz M, Walczak A, Bekiesinska-Figatowska M, Vielhaber S, Hallmann K, Stawinski P, Buehring S, Hsu DA, Kunz WS, Meisler MH, Ploski R.

Am J Hum Genet. 2016 Jul 7;99(1):188-94. doi: 10.1016/j.ajhg.2016.05.008. Epub 2016 Jun 9.

14.

Working Memory Network Changes in ALS: An fMRI Study.

Vellage AK, Veit M, Kobeleva X, Petri S, Vielhaber S, Müller NG.

Front Neurosci. 2016 Apr 19;10:158. doi: 10.3389/fnins.2016.00158. eCollection 2016.

15.

Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis.

Cardenas-Blanco A, Machts J, Acosta-Cabronero J, Kaufmann J, Abdulla S, Kollewe K, Petri S, Schreiber S, Heinze HJ, Dengler R, Vielhaber S, Nestor PJ.

Neuroimage Clin. 2016 Mar 16;11:408-414. doi: 10.1016/j.nicl.2016.03.011. eCollection 2016.

16.

Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients.

Schüle R, Wiethoff S, Martus P, Karle KN, Otto S, Klebe S, Klimpe S, Gallenmüller C, Kurzwelly D, Henkel D, Rimmele F, Stolze H, Kohl Z, Kassubek J, Klockgether T, Vielhaber S, Kamm C, Klopstock T, Bauer P, Züchner S, Liepelt-Scarfone I, Schöls L.

Ann Neurol. 2016 Apr;79(4):646-58. doi: 10.1002/ana.24611. Epub 2016 Mar 11.

PMID:
26856398
17.

Quantifying disease progression in amyotrophic lateral sclerosis using peripheral nerve sonography.

Schreiber S, Dannhardt-Stieger V, Henkel D, Debska-Vielhaber G, Machts J, Abdulla S, Kropf S, Kollewe K, Petri S, Heinze HJ, Dengler R, Nestor PJ, Vielhaber S.

Muscle Nerve. 2016 Sep;54(3):391-7. doi: 10.1002/mus.25066. Epub 2016 Jun 9.

PMID:
26840391
18.

No Change in Executive Performance in ALS Patients: A Longitudinal Neuropsychological Study.

Kasper E, Zydatiss K, Schuster C, Machts J, Bittner D, Kaufmann J, Benecke R, Vielhaber S, Teipel S, Prudlo J.

Neurodegener Dis. 2016;16(3-4):184-91. doi: 10.1159/000440957. Epub 2015 Nov 28.

PMID:
26613522
19.

Basal ganglia pathology in ALS is associated with neuropsychological deficits.

Machts J, Loewe K, Kaufmann J, Jakubiczka S, Abdulla S, Petri S, Dengler R, Heinze HJ, Vielhaber S, Schoenfeld MA, Bede P.

Neurology. 2015 Oct 13;85(15):1301-9. doi: 10.1212/WNL.0000000000002017. Epub 2015 Sep 18.

PMID:
26385880
20.

Structural hallmarks of amyotrophic lateral sclerosis progression revealed by probabilistic fiber tractography.

Steinbach R, Loewe K, Kaufmann J, Machts J, Kollewe K, Petri S, Dengler R, Heinze HJ, Vielhaber S, Schoenfeld MA, Stoppel CM.

J Neurol. 2015 Oct;262(10):2257-70. doi: 10.1007/s00415-015-7841-1. Epub 2015 Jul 10.

PMID:
26159103
21.

A new approach using high volume blood patch for prevention of post-dural puncture headache following intrathecal catheter pump exchange.

Abdulla S, Vielhaber S, Heinze HJ, Abdulla W.

Int J Crit Illn Inj Sci. 2015 Apr-Jun;5(2):93-8. doi: 10.4103/2229-5151.158395.

22.

Knockout of cyclophilin D in Ppif⁻/⁻ mice increases stability of brain mitochondria against Ca²⁺ stress.

Gainutdinov T, Molkentin JD, Siemen D, Ziemer M, Debska-Vielhaber G, Vielhaber S, Gizatullina Z, Orynbayeva Z, Gellerich FN.

Arch Biochem Biophys. 2015 Aug 1;579:40-6. doi: 10.1016/j.abb.2015.05.009. Epub 2015 May 29.

PMID:
26032335
23.

Dysexecutive functioning in ALS patients and its clinical implications.

Kasper E, Schuster C, Machts J, Bittner D, Vielhaber S, Benecke R, Teipel S, Prudlo J.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):160-71. doi: 10.3109/21678421.2015.1026267. Epub 2015 May 12.

PMID:
25967541
24.

Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis.

Körtvelyessy P, Bauer J, Stoppel CM, Brück W, Gerth I, Vielhaber S, Wiedemann FR, Heinze HJ, Bartels C, Bien CG.

Neurol Neuroimmunol Neuroinflamm. 2015 Feb 12;2(2):e75. doi: 10.1212/NXI.0000000000000075. eCollection 2015 Apr. No abstract available.

25.

Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.

Dorst J, Dupuis L, Petri S, Kollewe K, Abdulla S, Wolf J, Weber M, Czell D, Burkhardt C, Hanisch F, Vielhaber S, Meyer T, Frisch G, Kettemann D, Grehl T, Schrank B, Ludolph AC.

J Neurol. 2015;262(4):849-58. doi: 10.1007/s00415-015-7646-2. Epub 2015 Jan 25.

PMID:
25618254
26.

Microstructural white matter changes underlying cognitive and behavioural impairment in ALS--an in vivo study using DTI.

Kasper E, Schuster C, Machts J, Kaufmann J, Bittner D, Vielhaber S, Benecke R, Teipel S, Prudlo J.

PLoS One. 2014 Dec 11;9(12):e114543. doi: 10.1371/journal.pone.0114543. eCollection 2014.

27.

Hypertension drives parenchymal β-amyloid accumulation in the brain parenchyma.

Bueche CZ, Hawkes C, Garz C, Vielhaber S, Attems J, Knight RT, Reymann K, Heinze HJ, Carare RO, Schreiber S.

Ann Clin Transl Neurol. 2014 Feb;1(2):124-9. doi: 10.1002/acn3.27. Epub 2014 Jan 9.

28.

Structural and functional hallmarks of amyotrophic lateral sclerosis progression in motor- and memory-related brain regions.

Stoppel CM, Vielhaber S, Eckart C, Machts J, Kaufmann J, Heinze HJ, Kollewe K, Petri S, Dengler R, Hopf JM, Schoenfeld MA.

Neuroimage Clin. 2014 Jul 22;5:277-90. doi: 10.1016/j.nicl.2014.07.007. eCollection 2014.

29.

Peripheral nerve ultrasound in amyotrophic lateral sclerosis phenotypes.

Schreiber S, Abdulla S, Debska-Vielhaber G, Machts J, Dannhardt-Stieger V, Feistner H, Oldag A, Goertler M, Petri S, Kollewe K, Kropf S, Schreiber F, Heinze HJ, Dengler R, Nestor PJ, Vielhaber S.

Muscle Nerve. 2015 May;51(5):669-75. doi: 10.1002/mus.24431. Epub 2015 Mar 14.

PMID:
25155020
30.

Central white matter degeneration in bulbar- and limb-onset amyotrophic lateral sclerosis.

Cardenas-Blanco A, Machts J, Acosta-Cabronero J, Kaufmann J, Abdulla S, Kollewe K, Petri S, Heinze HJ, Dengler R, Vielhaber S, Nestor PJ.

J Neurol. 2014 Oct;261(10):1961-7. doi: 10.1007/s00415-014-7434-4. Epub 2014 Jul 25.

PMID:
25059391
31.

Longitudinal course of cortical thickness decline in amyotrophic lateral sclerosis.

Schuster C, Kasper E, Machts J, Bittner D, Kaufmann J, Benecke R, Teipel S, Vielhaber S, Prudlo J.

J Neurol. 2014 Oct;261(10):1871-80. doi: 10.1007/s00415-014-7426-4. Epub 2014 Jul 15.

PMID:
25022938
32.

The impact of physical impairment on emotional well-being in ALS.

Abdulla S, Vielhaber S, Kollewe K, Machts J, Heinze HJ, Dengler R, Petri S.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):392-7. doi: 10.3109/21678421.2014.932380. Epub 2014 Jul 10.

PMID:
25008979
33.

Information needs and information-seeking preferences of ALS patients and their carers.

Abdulla S, Vielhaber S, Machts J, Heinze HJ, Dengler R, Petri S.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):505-12. doi: 10.3109/21678421.2014.932385. Epub 2014 Jul 10.

PMID:
25007829
34.

Hippocampal degeneration in patients with amyotrophic lateral sclerosis.

Abdulla S, Machts J, Kaufmann J, Patrick K, Kollewe K, Dengler R, Heinze HJ, Petri S, Vielhaber S, Nestor PJ.

Neurobiol Aging. 2014 Nov;35(11):2639-2645. doi: 10.1016/j.neurobiolaging.2014.05.035. Epub 2014 Jun 11.

PMID:
25004891
35.

Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment.

Machts J, Bittner V, Kasper E, Schuster C, Prudlo J, Abdulla S, Kollewe K, Petri S, Dengler R, Heinze HJ, Vielhaber S, Schoenfeld MA, Bittner DM.

BMC Neurosci. 2014 Jun 30;15:83. doi: 10.1186/1471-2202-15-83.

36.

Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats.

Schreiber S, Drukarch B, Garz C, Niklass S, Stanaszek L, Kropf S, Bueche C, Held F, Vielhaber S, Attems J, Reymann KG, Heinze HJ, Carare RO, Wilhelmus MM.

J Alzheimers Dis. 2014;42 Suppl 3:S205-15. doi: 10.3233/JAD-132618.

PMID:
24825568
37.

6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson's disease: respirometric, histological, and behavioral analyses.

Kupsch A, Schmidt W, Gizatullina Z, Debska-Vielhaber G, Voges J, Striggow F, Panther P, Schwegler H, Heinze HJ, Vielhaber S, Gellerich FN.

J Neural Transm (Vienna). 2014 Oct;121(10):1245-57. doi: 10.1007/s00702-014-1185-3. Epub 2014 Mar 14.

PMID:
24627045
38.

Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases.

Hübers A, Marroquin N, Schmoll B, Vielhaber S, Just M, Mayer B, Högel J, Dorst J, Mertens T, Just W, Aulitzky A, Wais V, Ludolph AC, Kubisch C, Weishaupt JH, Volk AE.

Neurobiol Aging. 2014 May;35(5):1214.e1-6. doi: 10.1016/j.neurobiolaging.2013.11.034. Epub 2013 Dec 4.

PMID:
24378086
39.

Should a percutaneous dilational tracheostomy be guided with a bronchoscope?

Abdulla S, Conrad A, Vielhaber S, Eckhardt R, Abdulla W.

B-ENT. 2013;9(3):227-34.

PMID:
24273954
40.

Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study.

Schuster C, Kasper E, Machts J, Bittner D, Kaufmann J, Benecke R, Teipel S, Vielhaber S, Prudlo J.

J Neurol. 2013 Nov;260(11):2856-64. doi: 10.1007/s00415-013-7083-z. Epub 2013 Aug 31.

PMID:
23996101
41.

Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis.

Schuster C, Kasper E, Dyrba M, Machts J, Bittner D, Kaufmann J, Mitchell AJ, Benecke R, Teipel S, Vielhaber S, Prudlo J.

Neurobiol Aging. 2014 Jan;35(1):240-6. doi: 10.1016/j.neurobiolaging.2013.07.020. Epub 2013 Aug 28.

PMID:
23992619
42.

Working memory in ALS patients: preserved performance but marked changes in underlying neuronal networks.

Zaehle T, Becke A, Naue N, Machts J, Abdulla S, Petri S, Kollewe K, Dengler R, Heinze HJ, Vielhaber S, Müller NG.

PLoS One. 2013 Aug 8;8(8):e71973. doi: 10.1371/journal.pone.0071973. eCollection 2013.

43.

Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure.

Abdulla S, Vielhaber S, Körner S, Machts J, Heinze HJ, Dengler R, Petri S.

J Neurol. 2013 Sep;260(9):2242-55. doi: 10.1007/s00415-013-6955-6. Epub 2013 Jun 5.

PMID:
23736973
44.

The control of brain mitochondrial energization by cytosolic calcium: the mitochondrial gas pedal.

Gellerich FN, Gizatullina Z, Gainutdinov T, Muth K, Seppet E, Orynbayeva Z, Vielhaber S.

IUBMB Life. 2013 Mar;65(3):180-90. doi: 10.1002/iub.1131. Epub 2013 Feb 8. Review.

45.

Sonography of the median nerve in CMT1A, CMT2A, CMTX, and HNPP.

Schreiber S, Oldag A, Kornblum C, Kollewe K, Kropf S, Schoenfeld A, Feistner H, Jakubiczka S, Kunz WS, Scherlach C, Tempelmann C, Mawrin C, Dengler R, Schreiber F, Goertler M, Vielhaber S.

Muscle Nerve. 2013 Mar;47(3):385-95. doi: 10.1002/mus.23681. Epub 2013 Feb 4.

PMID:
23381770
46.

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.

Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein HG, Vielhaber S, Kästner A, Skalej M, Jordan W, Schiltz K, Klingbeil C, Wandinger KP, Bogerts B, Stoecker W.

JAMA Psychiatry. 2013 Mar;70(3):271-8. doi: 10.1001/2013.jamapsychiatry.86.

PMID:
23344076
47.

Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis.

Hadzhieva M, Kirches E, Wilisch-Neumann A, Pachow D, Wallesch M, Schoenfeld P, Paege I, Vielhaber S, Petri S, Keilhoff G, Mawrin C.

Neuroscience. 2013 Jan 29;230:94-101. doi: 10.1016/j.neuroscience.2012.11.021. Epub 2012 Nov 20.

PMID:
23178912
48.

Hirayama disease is a pure spinal motor neuron disorder--a combined DTI and transcranial magnetic stimulation study.

Boelmans K, Kaufmann J, Schmelzer S, Vielhaber S, Kornhuber M, Münchau A, Zierz S, Gaul C.

J Neurol. 2013 Feb;260(2):540-8. doi: 10.1007/s00415-012-6674-4. Epub 2012 Sep 25.

PMID:
23007195
49.

Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion.

Vielhaber S, Debska-Vielhaber G, Peeva V, Schoeler S, Kudin AP, Minin I, Schreiber S, Dengler R, Kollewe K, Zuschratter W, Kornblum C, Zsurka G, Kunz WS.

Acta Neuropathol. 2013 Feb;125(2):245-56. doi: 10.1007/s00401-012-1036-y. Epub 2012 Aug 28.

PMID:
22926664
50.

Oxygen glucose deprivation causes mitochondrial dysfunction in cultivated rat hippocampal slices: protective effects of CsA, its immunosuppressive congener [D-Ser](8)CsA, the novel non-immunosuppressive cyclosporin derivative Cs9, and the NMDA receptor antagonist MK 801.

Trumbeckaite S, Gizatullina Z, Arandarcikaite O, Röhnert P, Vielhaber S, Malesevic M, Fischer G, Seppet E, Striggow F, Gellerich FN.

Mitochondrion. 2013 Sep;13(5):539-47. doi: 10.1016/j.mito.2012.07.110. Epub 2012 Jul 21.

PMID:
22824458

Supplemental Content

Loading ...
Support Center